Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19

Ravindra Ganesh, Colin F. Pawlowski, John C. O'Horo, Lori L. Arndt, Richard F. Arndt, Sarah J. Bell, Dennis M. Bierle, Molly Destro Borgen, Sara N. Hanson, Alexander Heyliger, Jennifer J. Larsen, Patrick J. Lenehan, Robert Orenstein, Arjun Puranik, Leigh L. Speicher, Sidna M. Tulledge-Scheitel, A. J. Venkatakrishnan, Caroline G. Wilker, Andrew D. Badley, Raymund R. Razonable

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19'. Together they form a unique fingerprint.

Medicine & Life Sciences